Israel Englander Entera Bio Ltd. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.64 - $1.72 $6,024 - $16,190
9,413 Added 93.23%
19,510 $32,000
Q4 2023

Feb 14, 2024
BUY
$0.55 - $0.74 $5,553 - $7,471
10,097 New
10,097 $6,000
Q4 2022

Feb 14, 2023
BUY
$0.5 - $1.05 $17,984 - $37,766
35,968 Added 358.53%
46,000 $34,000
Q3 2022

Nov 14, 2022
SELL
$0.07 - $1.98 $478 - $13,529
-6,833 Reduced 40.52%
10,032 $10,000

Others Institutions Holding ENTX

# of Institutions
21
Shares Held
5.34M
Call Options Held
2.6K
Put Options Held
100
View Full List

About Entera Bio Ltd.

ENTX Quotes by TradingView
  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $49.8M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email